FDA: HeartWare Heart Device Appears to Meet Study Goal

The U.S. Food and Drug Administration said Monday that an experimental heart-pump device being developed by HeartWare International appears to have met its study goal, but the agency said it was concerned about strokes.
The Wall Street Journal